Clinical trial Recruiting at 1 site Observational Ages 40 to 80

Effects of physical activity on neuroinflammation in Parkinson's disease

Official title: Role of Physical Activity on Neuroinflammation in Parkinson's Disease

Run by IRCCS National Neurological Institute "C. Mondino" Foundation · NCT06977204 · Data updated 2026-11-12

This study is testing if being physically active can help reduce inflammation in the brains of people with Parkinson's disease.

More Parkinson Disease trials

Quick facts

Study typeObservational
Ages40 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorIRCCS National Neurological Institute "C. Mondino" Foundation
Academic / other
Locations1 site (Pavia, Pavia)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 31, 2025
Study endsJune 1, 2026
Registry record updatedMay 18, 2025
Trial IDNCT06977204 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 40 to 80 years with a clinical diagnosis of Parkinson's disease and a Hoehn & Yahr stage between 1 and 3.

Probably not a fit

Patients with significant cognitive decline, other neurological diseases, or those undergoing specific treatments like deep brain stimulation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between physical activity and neuroinflammation in individuals diagnosed with Parkinson's disease. It aims to understand how physical activity may influence inflammatory processes associated with the disease, particularly focusing on the role of neuroinflammation in disease progression. Participants will be assessed based on their physical activity levels and the presence of neuroinflammatory markers. The study includes individuals aged 40 to 80 years with a confirmed diagnosis of Parkinson's disease and specific clinical criteria.

Why it matters

Potential benefit: If successful, this study could provide insights into how physical activity may mitigate neuroinflammation and potentially slow the progression of Parkinson's disease.

How similar studies have gone: Previous studies have indicated a potential link between physical activity and reduced neuroinflammation in neurodegenerative diseases, suggesting that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects of both sexes, aged between 40 and 80 years (extremes included)
* Diagnosis of Parkinson's disease according to the clinical diagnostic criteria of the Movement Disorder Society
* Hoehn \& Yahr between 1 and 3

Exclusion Criteria:

* Concomitant diagnosis of other neurological diseases
* Presence of confirmed cognitive decline (MMSE \< 24)
* Presence of depression with (BDI \> 40)
* Patients with deep brain stimulation implant or undergoing DuoDopa therapy
* Presence of significant diseases affecting the musculoskeletal system
* Presence of internal medicine conditions, considered clinically significant by the investigator
* Acute or recent infections
* Body Mass Index (BMI) \>= 30
* Active smoking behavior
* Ongoing treatment with N-acetylcysteine or anti-oxidants
* Pregnancy or lactation

Where it's running

  • IRCCS Mondino Foundation
    Pavia, Pavia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.